Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. [electronic resource]
Producer: 20110804Description: 246-52 p. digitalISSN:- 2542-5641
- Adolescent
- Adult
- Antineoplastic Agents -- administration & dosage
- Benzamides
- Child
- Drug Administration Schedule
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Imatinib Mesylate
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prospective Studies
- Pyrimidines -- administration & dosage
- Transplantation, Homologous -- methods
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.